Skip to main content
. 2014 May 12;19(5):6031–6046. doi: 10.3390/molecules19056031

Table 1.

IC50 values (μM) of compounds [3](CF3SO3)4–[8](CF3SO3)4 on various human cancer cell lines (DU-145, A-549, HeLa) and on the noncancerous cell line HEK-293, as well as DNA melting temperatures (ΔTm).

Compound Half maximum inhibitory concentration in µM (IC50) a ΔTm (°C) b
DU-145 c A-549 d HeLa e HEK-293 f
doxorubicin 1.28 ± 0.2 0.85 ± 0.1 0.91 ± 0.2 NT 9.5
[3](CF3SO3)4 0.54 ± 0.2 0.50 ± 0.1 0.52 ± 0.2 62.0 ± 0.5 12.9
[4](CF3SO3)4 16.0 ± 0.4 3.18 ± 0.2 4.16 ± 0.3 31.2 ± 0.5 6.8
[5](CF3SO3)4 4.67 ± 0.2 0.67 ± 0.1 1.01 ± 0.3 41.3 ± 0.4 7.3
[6](CF3SO3)4 2.53 ± 0.2 0.84 ± 0.1 1.04 ± 0.3 40.3 ± 0.4 7.9
[7](CF3SO3)4 4.98 ± 0.3 2.01 ± 0.2 5.75 ± 0.2 62.1 ± 0.3 8.2
[8](CF3SO3)4 0.72 ± 0.2 0.67 ± 0.4 0.59 ± 0.2 70.8 ± 0.4 12.7

a 50% Inhibitory concentration, values averaged over three individual experiments; b Melting temperature measurements were performed after incubation for 12 h at 37 °C in PE buffer (10 mM NaH2PO4/Na2HPO4, 1 mM Na2EDTA) at pH 7.4 with a complex/DNA ratio of 1:1. CT DNA alone melts at 59.3 °C; c Prostate cancer; d Lung cancer; e Cervical cancer; f Normal human embryonic kidney cells; NT: Not tested.